Related references
Note: Only part of the references are listed.Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients
Skye R. S. Fishbein et al.
MSPHERE (2021)
Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation
Anne J. Gonzales-Luna et al.
ANAEROBE (2021)
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Current Status of Vancomycin Analytical Methods
Patricia Aleixa Do Nascimento et al.
JOURNAL OF AOAC INTERNATIONAL (2020)
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects
Kevin W. Garey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection
Kristine Cannon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection
Abrar K. Thabit et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Development of HPLC Methods for the Determination of Vancomycin in Human Plasma, Mouse Serum and Bronchoalveolar Lavage Fluid
Mao Hagihara et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2013)
Quality Assessment of U.S. Marketplace Vancomycin for Injection Products Using High-Resolution Liquid Chromatography-Mass Spectrometry and Potency Assays
Michael E. Hadwiger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
Milagros Gonzales et al.
BMC INFECTIOUS DISEASES (2010)
Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections
Karine Berthoin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study
Maria Jose de Jesus Valle et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
The Human Microbiome Project
Peter J. Turnbaugh et al.
NATURE (2007)
Evidence for biliary excretion of vancomycin into stool during intravenous therapy: Potential implications for rectal colonization with vancomycin-resistant enterococci
BP Currie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
